Sight Sciences, Inc.
Clinical trials sponsored by Sight Sciences, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- One surgery, two problems: new device takes on glaucoma and cataracts together Results expected Sep 2026 (estimated)
-
Glaucoma pressure fight: new device vs laser – which wins?
Disease control Stopped earlyThis study tested a new device (VISCO™360) against a standard laser treatment to lower eye pressure in adults with open-angle glaucoma. Only 29 people took part before the study was stopped early. The goal was to see which method works better and is safer for controlling the dise…
Sponsor: Sight Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Glaucoma device showdown ends early: only 10 patients enrolled
Disease control Stopped earlyThis study aimed to compare two surgical devices—the OMNI system and the iStent inject—for lowering eye pressure in people with open-angle glaucoma who already had cataract surgery. The trial was terminated early and only enrolled 10 participants, so results are limited. Both dev…
Sponsor: Sight Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Warm compress showdown: can a new device beat the old way for dry eye?
Symptom relief Stopped earlyThis study compared the TearCare system, a device that applies heat to the eyelids, to standard warm compresses and lid massage for people with dry eye disease. The goal was to see if TearCare is safe and better at improving tear stability and reducing eye discomfort. The study p…
Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC